0.2399
price up icon0.59%   0.0014
pre-market  Pre-market:  .24   0.000100   +0.04%
loading
cbdMD Inc stock is traded at $0.2399, with a volume of 338.94K. It is up +0.59% in the last 24 hours and down -11.48% over the past month.
See More
Previous Close:
$0.2385
Open:
$0.2376
24h Volume:
338.94K
Relative Volume:
0.30
Market Cap:
$1.35M
Revenue:
$23.45M
Net Income/Loss:
$-19.98M
P/E Ratio:
-0.019
EPS:
-12.63
Net Cash Flow:
$-2.65M
1W Performance:
+11.27%
1M Performance:
-11.48%
6M Performance:
-54.51%
1Y Performance:
-73.64%
1-Day Range:
Value
$0.23
$0.2489
1-Week Range:
Value
$0.21
$0.251
52-Week Range:
Value
$0.1811
$1.2499

cbdMD Inc Stock (YCBD) Company Profile

Name
Name
cbdMD Inc
Name
Phone
704-445-5800
Name
Address
4521 Sharon Road, Charlotte, NC
Name
Employee
50
Name
Twitter
@cbdmd_usa
Name
Next Earnings Date
2024-08-14
Name
Latest SEC Filings
Name
YCBD's Discussions on Twitter

Compare YCBD with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
YCBD
cbdMD Inc
0.2399 1.35M 23.45M -19.98M -2.65M -12.63
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
150.91 65.46B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.18 46.11B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.23 45.84B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
14.29 16.37B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
293.46 12.81B 2.76B 1.11B 898.10M 22.77

cbdMD Inc Stock (YCBD) Latest News

pulisher
Apr 21, 2025

cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion - Yahoo Finance

Apr 21, 2025
pulisher
Apr 21, 2025

cbdMD Announces $10.7M Financial Overhaul: Strategic Stock Conversion and 1:8 Reverse Split Coming May 2025 - Stock Titan

Apr 21, 2025
pulisher
Apr 10, 2025

cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting - TradingView

Apr 10, 2025
pulisher
Apr 10, 2025

cbdMD Eliminates $10.7M in Dividend Obligations: Major Financial Restructuring Approved - Stock Titan

Apr 10, 2025
pulisher
Apr 08, 2025

Herbal Oasis Announces Distribution Agreement to Launch Statewide in Alabama and Select Florida Panhandle Markets - Quantisnow

Apr 08, 2025
pulisher
Apr 07, 2025

SCHD ETF News, 4/7/2025 - The Globe and Mail

Apr 07, 2025
pulisher
Apr 07, 2025

cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval - Newsfile

Apr 07, 2025
pulisher
Apr 02, 2025

CBD Massage Oils: The Ultimate CBD Relaxation - cbdMD

Apr 02, 2025
pulisher
Mar 27, 2025

cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 3.1% – Here’s Why - Defense World

Mar 27, 2025
pulisher
Mar 19, 2025

cbdMD, Inc. Announces Closing of Underwritten Public Offering of 8.0% Series A Cumulative Convertible Preferred Stock and Full Exercise of Underwriter’s Over-allotment Option for Total Gross Proceeds of $16.5 Million - Business Wire

Mar 19, 2025
pulisher
Mar 19, 2025

cbdMD’s Pet Brand, Paw CBD, Sees Sales Increase 64% from March 2020 Quarter to June 2020 Quarter - Business Wire

Mar 19, 2025
pulisher
Mar 07, 2025

cbdMD, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Feb 22, 2025

cbdMD (NYSEAMERICAN:YCBD) Stock Price Up 1.5% – Time to Buy? - Defense World

Feb 22, 2025
pulisher
Feb 19, 2025

cbdMD announces additional conversions of its convertible notes - MSN

Feb 19, 2025
pulisher
Feb 15, 2025

cbdMD, Inc. (AMEX:YCBD) Q1 2025 Earnings Call Transcript - Insider Monkey

Feb 15, 2025
pulisher
Feb 14, 2025

cbdMD Achieves Profitability, Highlights Growth in Earnings Call - TipRanks

Feb 14, 2025
pulisher
Feb 14, 2025

cbdMD targets growth with new product launches and improved profitability in Q1 2025 - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

cbdMD Inc (YCBD) Q1 2025 Earnings Call Highlights: Achieving Profitability and Debt-Free Status By GuruFocus - Investing.com Canada

Feb 14, 2025
pulisher
Feb 13, 2025

cbdMD, Inc. Reports Improved Earnings Amid Industry Challenges - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

cbdMD posts first-quarter profit despite lower sales - Green Market Report

Feb 13, 2025
pulisher
Feb 13, 2025

cbdMD Generates $5.1 Million in Revenue, Positive Earnings - Yahoo Finance

Feb 13, 2025
pulisher
Feb 07, 2025

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results - The Kingston Whig-Standard

Feb 07, 2025
pulisher
Feb 07, 2025

cbdMD Earnings: Strategic Financial Review & Market Position Update Coming Feb 13 - StockTitan

Feb 07, 2025
pulisher
Feb 06, 2025

cbdMD Inc [YCBD] is 54.03% higher this YTD. Is it still time to buy? - The DBT News

Feb 06, 2025
pulisher
Feb 06, 2025

A Look at cbdMD Inc (YCBD) Shares in the Recent Past Indicates Growth - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

cbdMD Inc (YCBD)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

YCBD’s Stock Market Adventure: 62.61% YTD Growth Amidst Volatility - The InvestChronicle

Feb 04, 2025
pulisher
Feb 02, 2025

cbdMD Joins Forces with The Barstool Fund to Aid Small Businesses - cbdMD

Feb 02, 2025
pulisher
Jan 30, 2025

Taking on analysts’ expectations and winning: cbdMD Inc (YCBD) - SETE News

Jan 30, 2025
pulisher
Jan 28, 2025

CBD Hemp Oil Consumption Market Predicted at 17.97%CAGR to Cross 24.08 Billion USD by 2032 | Riot CBD, - EIN News

Jan 28, 2025
pulisher
Jan 15, 2025

cbdMD Announces It Has Fully Satisfied Its Notes - The Kingston Whig-Standard

Jan 15, 2025
pulisher
Jan 15, 2025

cbdMD Eliminates All Debt Through Early Note Conversion, Strengthens Financial Position - StockTitan

Jan 15, 2025
pulisher
Jan 08, 2025

cbdMD Announces Additional Conversions of Its Convertible Notes - The Kingston Whig-Standard

Jan 08, 2025
pulisher
Jan 04, 2025

cbdMD discloses NYSE listing compliance notice - MSN

Jan 04, 2025
pulisher
Jan 03, 2025

cbdMD receives NYSE non-compliance notice - MSN

Jan 03, 2025
pulisher
Jan 03, 2025

cbdMD Faces NYSE American Delisting Risk Over $2M Equity Requirement Shortfall - StockTitan

Jan 03, 2025
pulisher
Jan 03, 2025

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard - Yahoo Finance

Jan 03, 2025
pulisher
Dec 27, 2024

cbdMD (AMEX:YCBD) Stock Quotes, Forecast and News Summary - Benzinga

Dec 27, 2024
pulisher
Dec 24, 2024

cbdMD Expands Board with CEO T. Ronan Kennedy - MSN

Dec 24, 2024
pulisher
Dec 23, 2024

cbdMD Strengthens Leadership: CEO Kennedy Joins Board After Successful Business Turnaround - StockTitan

Dec 23, 2024
pulisher
Dec 23, 2024

cbdMD Announces Company's CEO Joins the Board of Directors - Newsfile

Dec 23, 2024
pulisher
Dec 19, 2024

cbdMD Launches Line of CBD Products with Wegmans Food Markets - Newsfile

Dec 19, 2024
pulisher
Dec 18, 2024

cbdMD posts lower annual sales, mixed fourth quarter - Green Market Report

Dec 18, 2024
pulisher
Dec 18, 2024

cbdMD Inc. (YCBD) reports earnings - Quartz

Dec 18, 2024
pulisher
Dec 18, 2024

cbdMD Slashes Losses by $19.1M Despite Sales Dip; Launches New Product Lines - StockTitan

Dec 18, 2024
pulisher
Dec 18, 2024

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results - The Kingston Whig-Standard

Dec 18, 2024
pulisher
Dec 18, 2024

Dream Industrial REIT (DIR-UN-T) QuotePress Release - The Globe and Mail

Dec 18, 2024
pulisher
Dec 17, 2024

cbdMD, Inc. Reschedules Earnings Release and Conference Call - Newsfile

Dec 17, 2024
pulisher
Dec 12, 2024

S&P 500 Information Technology [Sector] (SRIT) QuotePress Release - The Globe and Mail

Dec 12, 2024
pulisher
Dec 12, 2024

cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results - The Kingston Whig-Standard

Dec 12, 2024

cbdMD Inc Stock (YCBD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_specialty_generic PBH
$79.77
price down icon 0.57%
$27.15
price up icon 0.15%
$101.20
price up icon 1.64%
$7.81
price up icon 1.56%
$103.22
price up icon 1.45%
$293.46
price up icon 0.22%
Cap:     |  Volume (24h):